Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,638 | -713 | -13,812 | -13,654 | -13,654 |
| Depreciation Amortization | 807 | 34 | 9 | 19 | 20 |
| Accounts payable and accrued liabilities | 557 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,094 | 64 | 2,036 | -2,407 | 901 |
| Other Operating Activity | 1,900 | 374 | 835 | 804 | 806 |
| Operating Cash Flow | $-2,281 | $-241 | $-10,932 | $-15,238 | $-11,927 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 8,512 | -8,512 | N/A |
| PPE Investments | N/A | N/A | N/A | N/A | -13 |
| Net Acquisitions | 189 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $189 | $N/A | $8,512 | $-8,512 | $-13 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,088 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 83 | 240 | N/A | N/A | 9,194 |
| Financing Cash Flow | $2,171 | $240 | $N/A | $N/A | $9,194 |
| Beginning Cash Position | 3 | 4 | 3,535 | 27,285 | 30,031 |
| End Cash Position | 82 | 3 | 1,115 | 3,535 | 27,285 |
| Net Cash Flow | $80 | $-1 | $-2,420 | $-23,750 | $-2,746 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,281 | -241 | -10,932 | -15,238 | -11,927 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -13 |
| Free Cash Flow | -2,281 | -241 | -10,932 | -15,238 | -11,940 |